 Oyster Point Pharma NASDAQ:OYST has been given a consensus broker rating score of 1.00 Strong Buy from the three brokers that provide coverage for the company, Zacks Investment Research reports. Three research analysts have rated the stock with a strong buy rating. Analysts have set a 12 month consensus price target of 50.00 for the ... 